Sign in

CIK 0001745999

  • Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Option exercise President & CSO acquired 4,030 shares (option exercise)
  2. 4 Grant or award CFO acquired 17,500 shares (grant or award)
  3. 4 Other disposition Director disposed of 400,000 shares (other)
  4. 4 Other disposition Director disposed of 400,000 shares (other)
  5. 4 Other disposition 10% owner disposed of 400,000 shares (other)
  6. 4 Other disposition Director disposed of 800,000 shares (other)
  7. 4 Other disposition Director disposed of 800,000 shares (other)
  8. 4 Other disposition 10% owner disposed of 800,000 shares (other)
  9. 4 Other acquisition 10% owner acquired 356,673 shares (other)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale CFO sold 25,000 shares at an average $81.78 ($2,044,485)
  13. 4 Open-market sale President & CSO sold 43,842 shares at an average $83.26 ($3,650,144)
  14. 4 Open-market sale CEO sold 22,300 shares at an average $84.94 ($1,894,125)
  15. 4 Option exercise President & CSO acquired 3,731 shares (option exercise)
  16. 4 Option exercise CFO acquired 7,309 shares (option exercise)
  17. 4 Option exercise CEO acquired 115,000 shares (option exercise)
  18. 4 Other acquisition 10% owner acquired 356,674 shares (other)
  19. 4 Conversion 10% owner acquired 6,971,912 shares (conversion)
  20. 4 Conversion 10% owner acquired 1,161,458 shares (conversion)

Page 11 of 12 · 238 filings